Interestingly, the traditional SLE drug, mycophenolic acid (MPA, an immunosuppressant), was able to reverse the abnormal histone global hypoacetylation status in lupus CD4+ T cells by upregulating HAT expression and downregulating HDAC expression [53]. The gene discussed is TMPRSS11D; the disease is systemic lupus erythematosus.